GH Research PLC
GHRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855129
No open-market purchases or sales by GH Research PLC insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $1.38B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in GH Research PLC as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +3 vs. Q1 2022
- Shares held
- 32.6M
- +498.6K (+1.6%) vs. Q1 2022
- Total value
- $325.0M
- −$261.3M (−44.6%) vs. Q1 2022
- New holders
- 5
- 12 more added
- Sold out
- 2
- 8 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GHRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 63 | $1.38B |
| Q1 2026 | 54 | $668.5M |
| Q4 2025 | 53 | $591.4M |
| Q3 2025 | 47 | $618.1M |
| Q2 2025 | 38 | $530.9M |
| Q1 2025 | 36 | $470.1M |
| Q4 2024 | 31 | $214.9M |
| Q3 2024 | 28 | $204.2M |
| Q2 2024 | 28 | $354.8M |
| Q1 2024 | 32 | $315.5M |
| Q4 2023 | 35 | $171.7M |
| Q3 2023 | 29 | $291.5M |
| Q2 2023 | 34 | $351.6M |
| Q1 2023 | 29 | $237.2M |
| Q4 2022 | 32 | $299.5M |
| Q3 2022 | 34 | $367.2M |
| Q2 2022 | 35 | $325.0M |
| Q1 2022 | 33 | $587.1M |
| Q4 2021 | 30 | $701.0M |
| Q3 2021 | 30 | $625.2M |
| Q2 2021 | 34 | $593.7M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding GH Research PLC; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 20 | $0 | 0.00% | −6,358−99.7% | Reduced |
| Point72 Hong Kong Ltd | 80 | $1.00K | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 220 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 897 | $8.00K | 0.00% | +897 | New |
| Tortoise Investment Management, LLC | 4,081 | $41.0K | 0.01% | +4,081 | New |
| Exchange Traded Concepts, LLC | 4,885 | $49.0K | 0.00% | +3,853+373.4% | Added |
| Royal Bank of Canada | 5,466 | $55.0K | 0.00% | +5,466 | New |
| Virtus ETF Advisers LLC | 9,952 | $99.0K | 0.04% | +3,265+48.8% | Added |
| Private Advisor Group, LLC | 10,236 | $102.0K | 0.00% | +10,236 | New |
| BlackRock Inc. | 21,086 | $210.0K | 0.00% | +4,196+24.8% | Added |
| Penserra Capital Management LLC | 21,400 | $213.0K | 0.01% | −1,887−8.1% | Reduced |
| AdvisorShares Investments LLC | 24,835 | $248.0K | 0.07% | +5,461+28.2% | Added |
| PEAK6 Investments LLC | 23,317 | $276.7K | 0.01% | +23,317 | New |
| Barclays PLC | 32,090 | $320.0K | 0.00% | −2,002−5.9% | Reduced |
| Geode Capital Management, LLC | 45,303 | $452.0K | 0.00% | +320+0.7% | Added |
| DAFNA Capital Management LLC | 55,000 | $549.0K | 0.15% | 00.0% | Unchanged |
| HighVista Strategies LLC | 63,936 | $638.0K | 0.39% | +11,096+21.0% | Added |
| Mirae Asset Global Investments Co., Ltd. | 159,001 | $1.59M | 0.00% | +22,392+16.4% | Added |
| Pura Vida Investments, LLC | 208,527 | $2.08M | 0.33% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 231,300 | $2.31M | 0.01% | −41,200−15.1% | Reduced |
| Acuta Capital Partners, LLC | 243,250 | $2.43M | 1.36% | −176,382−42.0% | Reduced |
| Laurion Capital Management LP | 314,930 | $3.14M | 0.13% | 00.0% | Unchanged |
| Morgan Stanley | 478,619 | $4.78M | 0.00% | +57,171+13.6% | Added |
| TimesSquare Capital Management, LLC | 481,809 | $4.81M | 0.07% | −1,600−0.3% | Reduced |
| Deep Track Capital, LP | 499,400 | $4.98M | 0.34% | 00.0% | Unchanged |
| Verition Fund Management LLC | 608,124 | $6.07M | 0.13% | −434,975−41.7% | Reduced |
| Cormorant Asset Management, LP | 608,123 | $6.07M | 0.47% | 00.0% | Unchanged |
| Boxer Capital, LLC | 1,013,399 | $10.1M | 0.64% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,303,470 | $13.0M | 0.02% | +27,738+2.2% | Added |
| OrbiMed Advisors LLC | 1,622,060 | $16.2M | 0.31% | +193,328+13.5% | Added |
| RTW Investments, LP | 2,168,957 | $21.6M | 0.56% | 00.0% | Unchanged |
| VR Adviser, LLC | 3,185,573 | $31.8M | 6.26% | +1,134,513+55.3% | Added |
| Ra Capital Management, L.P. | 4,898,373 | $48.9M | 1.30% | +71,043+1.5% | Added |
| FMR LLC | 4,937,196 | $49.3M | 0.00% | −265,298−5.1% | Reduced |
| BVF Inc | 9,275,158 | $92.6M | 4.47% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |